Clinical Trials Browser

Malignant Solid Tumor × Clear all

NCT06057038 2026-03-03

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Malignant Solid Tumor

NCT06391775 2025-12-26

Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy

Phase 1/2 Terminated

Other solid neoplasm

Malignant Solid Tumor

NCT06735144 2025-12-05

Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Malignant Solid Tumor

NCT05859464 2025-10-20

A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Malignant Solid Tumor

NCT04632108 2025-09-11

A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Malignant Solid Tumor

NCT07136142 2025-08-22

A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Malignant Solid Tumor

NCT01309490 2025-07-29

Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients

Phase 1/2 Terminated

Other solid neoplasm

Malignant Solid Tumor

NCT03834662 2024-11-19

A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumor

NCT03192345 2024-08-07

A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumor

NCT03694249 2024-06-27

Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence

Phase 2 Active not recruiting

Other solid neoplasm

Malignant Solid Tumor

NCT04571892 2023-04-12

A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Malignant Solid Tumor

NCT02252211 2022-10-12

LUD2014-002

Phase 1 Completed

9 enrolled 25 charts

Other solid neoplasm

Malignant Solid Tumor

NCT01515306 2022-03-08

A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors

Phase 2 Completed

48 enrolled 17 charts

Other solid neoplasm

Malignant Solid Tumor

NCT01457118 2021-07-12

An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies

Phase 2 Completed

27 enrolled 18 charts

Other solid neoplasm

Malignant Solid Tumor

NCT03009214 2021-05-10

A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumor

NCT00836888 2020-10-08

ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan

Phase 1 Completed

17 enrolled 18 charts

Other solid neoplasm

Malignant Solid Tumor

NCT03553108 2020-10-01

IVIVC

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumor

NCT04076137 2019-09-03

Targeted T-cell Therapy in Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Malignant Solid Tumor

NCT01632696 2017-07-11

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Malignant Solid Tumor

NCT02999750 2016-12-21

EXtendedAnalysis for Cancer Treatment

Phase NA Unknown

Other solid neoplasm

Malignant Solid Tumor

NCT01567163 2014-10-16

A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors

Phase 2 Completed

22 enrolled 15 charts

Other solid neoplasm

Malignant Solid Tumor